SBRT in Early Breast Cancer in Elderly Women

Surgical treatment represents the standard of local therapy in patients with early breast cancer, however in women over75, the comorbidities related to aging reduce the possibility of candidates for surgical treatment. In the United Kingdom it is estimated that over 40% of elderly women do not receive surgery for their breast cancer, and that their primary treatment is hormonal only, the so-called primary endocrinotherapy. In Italy the recent AIOM guidelines of 2019 exclude, in patients with hormone-sensitive disease and age older than 70, the omission of surgery in favor of hormone therapy a

Trial Details

NCT ID
NCT05071105
Phase
NA
Sponsor
University of Rome Tor Vergata
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Stereotactic Body Radiation Therapy
Locations (sample)
  • Rome, Rome, Italy|41.89193,12.51133

Key Eligibility Criteria

  • Age ≥ 75 years
  • Histologically confirmed diagnosis of local disease only (cT1-T2 N0 M0)
  • Luminal like A or B (estrogen receptor positive and/or progesterone receptor positive and Her2 negative Tumors)
  • SBRT within 2 months after hormonal therapy start

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →